Literature DB >> 15771577

B cell signaling and tumorigenesis.

Hassan Jumaa1, Rudolf W Hendriks, Michael Reth.   

Abstract

The proliferation and differentiation of lymphocytes are regulated by receptors localized on the cell surface. Engagement of these receptors induces the activation of intracellular signaling proteins that transmit the receptor signals to distinct targets and control the cellular responses. The first signaling proteins to be discovered in higher organisms were the products of oncogenes. For example, the kinases Src and Abelson (Abl) were originally identified as oncogenes and were later characterized as important proteins for signal transduction in various cell types, including lymphocytes. Now, as many cellular signaling molecules have been discovered and ordered into certain pathways, we can better understand why particular signaling proteins are associated with tumorigenesis. In this review, we discuss recent progress in unraveling the molecular mechanisms of signaling pathways that control the proliferation and differentiation of early B cells. We point out the concepts of auto-inhibition and subcellular localization as crucial aspects in the regulation of B cell signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771577     DOI: 10.1146/annurev.immunol.23.021704.115606

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  38 in total

1.  Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.

Authors:  Sergei Radaev; Zhongcheng Zou; Pavel Tolar; Khanh Nguyen; AnhThao Nguyen; Peter D Krueger; Nicole Stutzman; Susan Pierce; Peter D Sun
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

2.  Drug discovery: New Btk inhibitor holds promise.

Authors:  Rudi W Hendriks
Journal:  Nat Chem Biol       Date:  2011-01       Impact factor: 15.040

3.  Engineering and characterization of a single chain surrogate light chain variable domain.

Authors:  Lucia Morstadt; Andrew Bohm; Deniz Yüksel; Krishna Kumar; B David Stollar; James D Baleja
Journal:  Protein Sci       Date:  2008-03       Impact factor: 6.725

4.  c-Abl-deficient mice exhibit reduced numbers of peritoneal B-1 cells and defects in BCR-induced B cell activation.

Authors:  Rachel A Liberatore; Stephen P Goff
Journal:  Int Immunol       Date:  2009-02-19       Impact factor: 4.823

Review 5.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

6.  Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin.

Authors:  Greg P Coffey; Ranjani Rajapaksa; Raymond Liu; Orr Sharpe; Chiung-Chi Kuo; Sharon Wald Krauss; Yael Sagi; R Eric Davis; Louis M Staudt; Jeff P Sharman; William H Robinson; Shoshana Levy
Journal:  J Cell Sci       Date:  2009-08-04       Impact factor: 5.285

Review 7.  B-cell receptor pathobiology and targeting in NHL.

Authors:  Ines M Macias-Perez; Ian W Flinn
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

8.  The selective SYK inhibitor P505-15 (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.

Authors:  Stephen E Spurgeon; Greg Coffey; Luke B Fletcher; Russell Burke; Jeffrey W Tyner; Brian J Druker; Andreas Betz; Francis DeGuzman; Yvonne Pak; Dale Baker; Anjali Pandey; Stanley J Hollenbach; Uma Sinha; Marc M Loriaux
Journal:  J Pharmacol Exp Ther       Date:  2012-12-07       Impact factor: 4.030

9.  Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.

Authors:  Xiaomin Zheng; Claudia Oancea; Reinhard Henschler; Malcolm A S Moore; Martin Ruthardt
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

10.  Dual nature of the adaptive immune system in lampreys.

Authors:  Peng Guo; Masayuki Hirano; Brantley R Herrin; Jianxu Li; Cuiling Yu; Andrea Sadlonova; Max D Cooper
Journal:  Nature       Date:  2009-05-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.